"[CB22010A58B7]" . "Kope\u010Dek, Miloslav" . "RIV/00023752:_____/05:00000818!RIV09-MSM-00023752" . "Z(MSM0021620816)" . "ziprasidone; side effects; galactorrhea; prolactin"@en . . . "\u00DAvod: Antipsychotika 2. generace nemaj\u00ED typick\u00E9 ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky konven\u010Dn\u00EDch antipsychotik. Metodika: 34-let\u00E1 pacientka s periodickou depresivn\u00ED poruchou (dle MKN-10) a opakovan\u00FDm sebepo\u0161kozen\u00EDm byla l\u00E9\u010Dena lithiem, clonazepamem a ziprasidonem. V\u00FDsledky: Dev\u00E1t\u00FD den l\u00E9\u010Dby ziprasidonem se objevila galaktorhea. Ta trvala do 36. dne l\u00E9\u010Dby ziprasidonem. Hladina prolaktinu byla 28 ng/ml. Horm\u00F3ny \u0161t\u00EDtn\u00E9 \u017El\u00E1zy (TSH, T3,T4) a plasmatick\u00E1 hladina lithia byly po dobu l\u00E9\u010Dby ziprasidonem v norm\u00E1ln\u00EDm rozmez\u00ED. Galaktorhea zmizela dva t\u00FDdny po vysazen\u00ED ziprasidonu a hladina prolaktinu poklesla na 18 ng/ml. Z\u00E1v\u011Br: Psychiat\u0159i si mus\u00ED b\u00FDt v\u011Bdom\u00ED skute\u010Dnosti, \u017Ee i antipsychotika 2. generace jako ziprasidon, maj\u00ED potenci\u00E1l vyvol\u00E1vat vedlej\u0161\u00ED \u00FA\u010Dinky vypl\u00FDvaj\u00EDc\u00ED z blok\u00E1dy dopaminov\u00FDch D2 receptor\u016F, jako je nap\u0159\u00EDklad galaktorhea."@cs . "Ziprasidone-induced galactorrhea: A case report"@en . "Mohr, Pavel" . . . . "Bare\u0161, Martin" . "Ziprasidonem indukovana galactorrhea: Kazuistika"@cs . "552127" . . . . . "26" . "SE - \u0160v\u00E9dsk\u00E9 kr\u00E1lovstv\u00ED" . "1" . . "Neuroendocrinology Letters" . . "RIV/00023752:_____/05:00000818" . "Objectives: Second-generation antipsychotics presumably lack the typical side effects of conventional antipsychotics. Methodology: A 34 year old Caucasian woman with ICD-10 diagnosis of Recurrent depressive disorder with current moderate symptoms, and with a history of repeated self-injury was treated with lithium, clonazepam and ziprasidone. The plasma levels of prolactin were determined by the Microparticle Enzyme Immunoassay on 14th day of ziprasidone treatment and two weeks after the ziprasidone withdrawal. Results: On the ninth day of ziprasidone administration, galactorrhea appeared. After 36 days of ziprasidone therapy, galactorrhea persisted. The prolactin plasma level was 28 ng/ml. Thyroid tests and the lithium plasma level were within the normal range during ziprasidone treatment. Two weeks after the ziprasidone withdrawal, galactorrhea disappeared and the prolactin level decreased down to 18 ng/ml. Conclusion: Psychiatrists should be aware that even second-generation antipsychotics, includ" . "Ziprasidone-induced galactorrhea: A case report" . . "Ziprasidone-induced galactorrhea: A case report" . . "0172-780X" . . "Objectives: Second-generation antipsychotics presumably lack the typical side effects of conventional antipsychotics. Methodology: A 34 year old Caucasian woman with ICD-10 diagnosis of Recurrent depressive disorder with current moderate symptoms, and with a history of repeated self-injury was treated with lithium, clonazepam and ziprasidone. The plasma levels of prolactin were determined by the Microparticle Enzyme Immunoassay on 14th day of ziprasidone treatment and two weeks after the ziprasidone withdrawal. Results: On the ninth day of ziprasidone administration, galactorrhea appeared. After 36 days of ziprasidone therapy, galactorrhea persisted. The prolactin plasma level was 28 ng/ml. Thyroid tests and the lithium plasma level were within the normal range during ziprasidone treatment. Two weeks after the ziprasidone withdrawal, galactorrhea disappeared and the prolactin level decreased down to 18 ng/ml. Conclusion: Psychiatrists should be aware that even second-generation antipsychotics, includ"@en . . . "Ziprasidone-induced galactorrhea: A case report"@en . "3"^^ . . "3"^^ . "2"^^ . . "Ziprasidonem indukovana galactorrhea: Kazuistika"@cs .